The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Factors such as the introduction of innovative treatment options, rising disposable incomes ... such as diabetic retinopathy and computer vision syndrome, is contributing to market expansion.

According to experts, soon the integration of artificial intelligence (AI) into healthcare will drastically shift from a novelty, to a critical resource. With over 800 FDA-cleared health AI ...

From a 14-year-old innovator in Frisco to an up-and-coming healthcare C-Suiter, these five up-and-comers are driving change ...

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 17, 2025 /PRNewswire/ -- According to experts, soon the integration of artificial intelligence ...

Insurance coverage for intravitreal injections, an essential treatment for diabetic retinopathy, depends on the specific terms and conditions of an individual’s health insurance policy.

Early detection and monitoring are key to the diagnosis and management of ocular diseases, including glaucoma, retinal and ...

Regular insulin, which is often used in pregnancy for the treatment of diabetes ... teratogenicity and embryotoxicity, and retinopathy. Teratogenicity and embryotoxicity: studies on experimental ...